(Total Views: 613)
Posted On: 07/04/2020 11:06:54 AM
Post# of 72447
Who did the new company overview of Brilacidin from June in the Update section of the website?
I know there was an Indian-sounding name of a Dr. or researcher still possibly with IPIX, maybe someone at LW, or one of our scientific advisors?
Or could it have been a hired temp just to do that write-up?
Expect some excitement this week what with the BP antibiotic announcement scheduled for this week and the CV therapeutic update scheduled for Wed, 9 July.
Whether we get news or not, obviously LOTS going on behind the scene at IPIX.
Keep picking up little by little additional stock (pretty well tapped out now) as time is now in our favor and new buys should bring about a very fast ROI IMO.
As for Remsdesivir (sp?) I don't see how anyone could take it seriously when so many on the CV panel are also investors in Gilead. Govt pays for getting it thru the system and Gilead turns around and sticks it to the govt for skyhigh price. Seems more of the same ol' same ol' pigs feasting at the govt trough.
I know there was an Indian-sounding name of a Dr. or researcher still possibly with IPIX, maybe someone at LW, or one of our scientific advisors?
Or could it have been a hired temp just to do that write-up?
Expect some excitement this week what with the BP antibiotic announcement scheduled for this week and the CV therapeutic update scheduled for Wed, 9 July.
Whether we get news or not, obviously LOTS going on behind the scene at IPIX.
Keep picking up little by little additional stock (pretty well tapped out now) as time is now in our favor and new buys should bring about a very fast ROI IMO.
As for Remsdesivir (sp?) I don't see how anyone could take it seriously when so many on the CV panel are also investors in Gilead. Govt pays for getting it thru the system and Gilead turns around and sticks it to the govt for skyhigh price. Seems more of the same ol' same ol' pigs feasting at the govt trough.
(5)
(0)
